Workup for Hyperosmolar Hyperglycemic State
The essential workup for HHS requires immediate measurement of serum glucose, calculated serum osmolality, electrolytes (particularly sodium and potassium), renal function, venous pH, and assessment of hydration status and mental status, with diagnostic criteria being glucose ≥30 mmol/L (540 mg/dL), osmolality ≥320 mOsm/kg, pH >7.3, bicarbonate ≥15 mmol/L, and ketones ≤3.0 mmol/L 1, 2.
Diagnostic Criteria
The diagnosis of HHS is established through specific biochemical thresholds, though minor variations exist between guidelines:
- Hyperglycemia: Glucose ≥30.0 mmol/L (540 mg/dL) per JBDS guidelines 2, or ≥33.3 mmol/L (600 mg/dL) per ADA/Diabetes Canada 3
- Hyperosmolality: Calculated serum osmolality ≥320 mOsm/kg using the formula: (2 × Na+) + glucose + urea 2
- Absence of significant ketoacidosis: Ketones ≤3.0 mmol/L, pH >7.3, bicarbonate ≥15 mmol/L 2
This distinguishes HHS from DKA, though mixed presentations can occur 2.
Initial Laboratory Assessment
Core Laboratory Tests (Check Every 2-4 Hours Until Stable)
- Serum glucose: To confirm hyperglycemia and monitor treatment response 1
- Electrolytes with calculated osmolality: Serial measurements are critical as osmolality should decline by 3-8 mOsm/kg/h to minimize neurological complications like central pontine myelinolysis 2, 4
- Serum sodium: An initial rise is expected with treatment and is not itself an indication for hypotonic fluids 4
- Serum potassium: Check every 2 hours initially, as hypokalaemia occurs in ~50% of cases during treatment and severe hypokalaemia (<2.5 mEq/L) increases mortality 5
- Renal function (BUN/creatinine): To assess degree of dehydration and establish adequate renal function (urine output ≥0.5 mL/kg/h) before potassium replacement 1, 2
- Venous pH and bicarbonate: To exclude significant acidosis and rule out mixed DKA/HHS 1, 2
Clinical Assessment Parameters
- Hydration status: Estimate fluid deficit (typically 100-220 mL/kg) through clinical examination including skin turgor, mucous membranes, hemodynamic parameters 2
- Mental status: Document baseline cognitive function, as altered mental status is the most common neurologic manifestation and should return to pre-morbid state with treatment 2, 6
- Urine output: Target ≥0.5 mL/kg/h to confirm adequate renal perfusion 2
Identification of Precipitating Factors
A critical component of the workup involves identifying underlying triggers 1:
- Infection workup: Most common precipitant (44% of cases) 7. Obtain cultures (blood, urine, sputum as indicated), chest X-ray, urinalysis
- Cardiovascular events: ECG and cardiac biomarkers to exclude myocardial infarction (3.9% complication rate) 7
- Medication review: Assess for non-adherence to diabetes medications or new medications that impair glucose control (steroids, antipsychotics)
- New diabetes diagnosis: Present in 31.7% of HHS cases 7
Monitoring Frequency
Check electrolytes, renal function, venous pH, osmolality, and glucose every 2-4 hours until stable 1. More frequent monitoring (every 1-2 hours) may be needed for potassium during active treatment 5.
Important Caveats
- Osmolality calculation is mandatory: Unlike DKA, the rate of osmolality decline (not just glucose) determines treatment success and prevents devastating neurological complications 2, 4
- Do not rely on glucose alone: HHS develops over days (not hours like DKA), and the metabolic derangements are more extreme despite less acidosis 4
- Phosphate measurement: Only check if there is muscle weakness, respiratory compromise, or cardiac dysfunction—routine replacement is not recommended 1
- Mixed presentations exist: Some patients have features of both DKA and HHS; check ketones in all cases 2
The workup must be systematic and repeated frequently, as HHS carries mortality rates up to 20% (significantly higher than DKA's 1-5%) 7, 8, making early recognition and aggressive monitoring essential for survival.